Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
615.00 GBX | +1.99% | +4.33% | +13.47% |
Jan. 24 | Materials Down on Flight From Rate-Sensitive Sectors -- Materials Roundup | DJ |
Jan. 24 | International Paper-DS Smith Merger Gets EU Regulator's Conditional Approval | MT |
Fiscal Period: April | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 3.75 | 2.56 | 3 | 4.83 | 4.02 | |||||
Return on Total Capital | 5.37 | 3.61 | 4.37 | 7.29 | 5.81 | |||||
Return On Equity % | 8.97 | 5.29 | 7.21 | 11.83 | 9.58 | |||||
Return on Common Equity | 8.98 | 5.29 | 7.21 | 11.81 | 9.59 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 10.92 | 8.36 | 8.11 | 10.47 | 10.28 | |||||
SG&A Margin | 0.05 | 0.05 | 0.04 | 0.01 | 0.01 | |||||
EBITDA Margin % | 14.58 | 11.77 | 10.88 | 13.15 | 13.66 | |||||
EBITA Margin % | 10.87 | 7.92 | 7.84 | 10.22 | 10.04 | |||||
EBIT Margin % | 8.51 | 5.93 | 6.16 | 9.09 | 8.82 | |||||
Income From Continuing Operations Margin % | 4.8 | 3.05 | 3.87 | 5.98 | 5.64 | |||||
Net Income Margin % | 8.72 | 3.25 | 3.87 | 6.11 | 5.64 | |||||
Net Avail. For Common Margin % | 4.8 | 3.05 | 3.87 | 5.97 | 5.64 | |||||
Normalized Net Income Margin | 4.52 | 2.97 | 3.33 | 5.13 | 4.6 | |||||
Levered Free Cash Flow Margin | 10.36 | 4.58 | 1.9 | 7.24 | -3.63 | |||||
Unlevered Free Cash Flow Margin | 11.12 | 5.28 | 2.4 | 7.7 | -2.58 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.71 | 0.69 | 0.78 | 0.85 | 0.73 | |||||
Fixed Assets Turnover | 1.94 | 1.82 | 2.19 | 2.32 | 1.76 | |||||
Receivables Turnover (Average Receivables) | 7.25 | 9.98 | 8.84 | 8.13 | 7.18 | |||||
Inventory Turnover (Average Inventory) | 9.66 | 10.27 | 10.62 | 11.03 | 10.03 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 0.88 | 0.93 | 0.87 | 0.83 | 0.86 | |||||
Quick Ratio | 0.63 | 0.64 | 0.55 | 0.54 | 0.58 | |||||
Operating Cash Flow to Current Liabilities | 0.29 | 0.31 | 0.26 | 0.28 | 0.12 | |||||
Days Sales Outstanding (Average Receivables) | 50.48 | 36.59 | 41.31 | 44.89 | 50.99 | |||||
Days Outstanding Inventory (Average Inventory) | 37.87 | 35.56 | 34.37 | 33.1 | 36.5 | |||||
Average Days Payable Outstanding | 122.63 | 76.94 | 85.48 | 87.65 | 84.86 | |||||
Cash Conversion Cycle (Average Days) | -34.28 | -4.8 | -9.81 | -9.66 | 2.64 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 81.86 | 74.68 | 55.46 | 52.46 | 70.02 | |||||
Total Debt / Total Capital | 45.01 | 42.75 | 35.67 | 34.41 | 41.18 | |||||
LT Debt/Equity | 74.07 | 63.37 | 36.16 | 46.39 | 55.81 | |||||
Long-Term Debt / Total Capital | 40.73 | 36.28 | 23.26 | 30.43 | 32.83 | |||||
Total Liabilities / Total Assets | 61.15 | 59.37 | 57.17 | 56.78 | 57.33 | |||||
EBIT / Interest Expense | 6.95 | 5.29 | 7.69 | 12.45 | 5.23 | |||||
EBITDA / Interest Expense | 12.88 | 11.6 | 14.79 | 19.2 | 8.77 | |||||
(EBITDA - Capex) / Interest Expense | 7.8 | 6.66 | 7.36 | 10.12 | 4.01 | |||||
Total Debt / EBITDA | 2.88 | 3.4 | 2.74 | 1.86 | 2.74 | |||||
Net Debt / EBITDA | 2.25 | 2.35 | 1.78 | 1.45 | 2.25 | |||||
Total Debt / (EBITDA - Capex) | 4.75 | 5.92 | 5.5 | 3.53 | 6 | |||||
Net Debt / (EBITDA - Capex) | 3.72 | 4.09 | 3.58 | 2.75 | 4.92 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -2.07 | -1.11 | 21.17 | 13.53 | -17.02 | |||||